Philip N. Sambrook

32.1k total citations · 5 hit papers
256 papers, 21.3k citations indexed

About

Philip N. Sambrook is a scholar working on Orthopedics and Sports Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Philip N. Sambrook has authored 256 papers receiving a total of 21.3k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Orthopedics and Sports Medicine, 69 papers in Oncology and 53 papers in Pathology and Forensic Medicine. Recurrent topics in Philip N. Sambrook's work include Bone health and osteoporosis research (155 papers), Bone health and treatments (65 papers) and Bone and Joint Diseases (42 papers). Philip N. Sambrook is often cited by papers focused on Bone health and osteoporosis research (155 papers), Bone health and treatments (65 papers) and Bone and Joint Diseases (42 papers). Philip N. Sambrook collaborates with scholars based in Australia, United States and United Kingdom. Philip N. Sambrook's co-authors include John A. Eisman, Tuan V. Nguyen, Paul J. Kelly, Nicholas Pocock, Cyrus Cooper, Lyn March, Diane L. Schneider, Graeme Jones, Nigel A. Morrison and Alex J. MacGregor and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Philip N. Sambrook

253 papers receiving 20.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of bone density from vitamin D receptor alleles

1994 1.6k citations Paul J. Kelly, Tuan V. Nguyen et al. profile →
Mortality after all major types of osteoporotic fracture in men and women: an observational study

1999 1.5k citations Tuan V. Nguyen, Philip N. Sambrook et al. profile →
Genetic determinants of bone mass in adults. A twin study.

1987 1.0k citations Nicholas Pocock, John A. Eisman et al. Journal of Clinical Investigation profile →
Osteoporosis

2006 948 citations Philip N. Sambrook et al. profile →
Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study

2011 366 citations Philip N. Sambrook, Alex J. MacGregor et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip N. Sambrook Australia	77	11.7k	5.1k	4.8k	4.5k	4.4k	256	21.3k
René Rizzoli Switzerland	90	15.9k 1.4×	6.6k 1.3×	4.6k 0.9×	6.6k 1.5×	7.5k 1.7×	476	30.4k
Steven Boonen Belgium	93	15.1k 1.3×	7.0k 1.4×	4.8k 1.0×	6.8k 1.5×	7.7k 1.8×	392	29.4k
Dan Mellström Sweden	62	11.1k 0.9×	5.0k 1.0×	2.2k 0.5×	4.7k 1.0×	5.4k 1.2×	314	19.9k
Huibert A. P. Pols Netherlands	90	11.9k 1.0×	7.0k 1.4×	5.0k 1.0×	6.9k 1.5×	5.0k 1.1×	238	31.6k
Maria Luisa Brandi Italy	83	8.8k 0.7×	6.4k 1.2×	3.7k 0.8×	7.9k 1.8×	8.8k 2.0×	770	29.6k
Juliet Compston United Kingdom	71	12.0k 1.0×	4.5k 0.9×	2.5k 0.5×	7.6k 1.7×	6.6k 1.5×	324	22.5k
Peter R. Ebeling Australia	80	6.8k 0.6×	4.4k 0.9×	5.6k 1.2×	4.2k 0.9×	5.0k 1.1×	568	23.6k
Jonathan D. Adachi Canada	77	14.3k 1.2×	7.1k 1.4×	2.5k 0.5×	5.0k 1.1×	7.5k 1.7×	483	22.5k
John A. Eisman Australia	95	18.3k 1.6×	8.6k 1.7×	7.7k 1.6×	6.8k 1.5×	6.4k 1.5×	332	30.1k
Ian R. Reid New Zealand	98	17.2k 1.5×	4.2k 0.8×	6.8k 1.4×	8.4k 1.9×	11.0k 2.5×	492	31.4k

Countries citing papers authored by Philip N. Sambrook

Since Specialization

Citations

This map shows the geographic impact of Philip N. Sambrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip N. Sambrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip N. Sambrook more than expected).

Fields of papers citing papers by Philip N. Sambrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip N. Sambrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip N. Sambrook. The network helps show where Philip N. Sambrook may publish in the future.

Co-authorship network of co-authors of Philip N. Sambrook

This figure shows the co-authorship network connecting the top 25 collaborators of Philip N. Sambrook. A scholar is included among the top collaborators of Philip N. Sambrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip N. Sambrook. Philip N. Sambrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makovey, Joanna, Monique Macara, Jian Sheng Chen, et al.. (2012). High osteoporotic fracture risk and CVD risk co-exist in postmenopausal women. Bone. 52(1). 120–125. 17 indexed citations

Sambrook, Philip N., et al.. (2012). Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. The HKU Scholars Hub (University of Hong Kong). 48 indexed citations

Anandacoomarasamy, Ananthila, Steven Leibman, Garett Smith, et al.. (2011). Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage. Annals of the Rheumatic Diseases. 71(1). 26–32. 124 indexed citations

Reid, David M., Jean‐Pierre Devogelaer, Kenneth G. Saag, et al.. (2009). Zoledronic Acid and Risedronate in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Trial): A Multicentre, Double-Blind, Double-Dummy, Randomized Controlled Trial. Obstetrical & Gynecological Survey. 64(8). 521–523. 1 indexed citations

Reid, Donald, Jean‐Pierre Devogelaer, Christian Roux, et al.. (2008). A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO). Open Repository and Bibliography (University of Liège). 1 indexed citations

Sambrook, Philip N., Jean‐Pierre Devogelaer, J.-Y. Reginster, et al.. (2008). Effect of a Single 5-mg Infusion of Zoledronic Acid on Bone Turnover Markers Versus Oral Risedronate (5 mg/day) Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis.. Journal of Bone and Mineral Research. 23. 1 indexed citations

Roux, C., Jean‐Pierre Devogelaer, Donald Reid, et al.. (2008). Effect of Zoledronic Acid (Single 5-mg Infusion) on Lumbar Spine Bone Mineral Density Versus Oral Risedronate (5 mg/day) Over 1 Year in Subgroups of Patients Receiving Glucocorticoid Therapy.. Journal of Bone and Mineral Research. 23. 1 indexed citations

Makovey, Joanna, Tuan V. Nguyen, Vasi Naganathan, John D. Wark, & Philip N. Sambrook. (2007). Genetic Effects on Bone Loss in Peri- and Postmenopausal Women: A Longitudinal Twin Study. Journal of Bone and Mineral Research. 22(11). 1773–1780. 51 indexed citations

Williams, Frances M. K., Nisha J. Manek, Philip N. Sambrook, Tim D. Spector, & Alex J. MacGregor. (2007). Schmorl's nodes: Common, highly heritable, and related to lumbar disc disease. Arthritis Care & Research. 57(5). 855–860. 118 indexed citations

10.

Sambrook, Philip N., Jean‐Yves Reginster, R. R. Recker, et al.. (2004). Novel ibandronate regimens in postmenopausal osteoporosis: design of the dosing intravenous administration (DIVA) study. Osteoporosis International. 15. 1 indexed citations

11.

Sambrook, Philip N., et al.. (2003). Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the Rheumatic Diseases. 62(12). 1215–1217. 35 indexed citations

12.

Naganathan, Vasi & Philip N. Sambrook. (2001). Osteoporosis and Fracture Risk Prevention in Long-term Glucocorticoid Therapy—Reply. JAMA Internal Medicine. 161(14). 1780–1780. 1 indexed citations

13.

Sambrook, Philip N., et al.. (2001). The musculoskeletal system. Churchill Livingstone eBooks. 3 indexed citations

14.

Hunter, David, et al.. (1999). Corticosteroids, osteoporosis and the Australian rheumatologist. APLAR Journal of Rheumatology. 3(11). 326–330. 1 indexed citations

15.

Naganathan, Vasi, Peter Nash, Graeme Jones, Geoffrey C. Nicholson, & Philip N. Sambrook. (1999). Vertebral fracture risk with long-term corticosteroids: Relationship to age and bone density.. Journal of Bone and Mineral Research. 14. 1 indexed citations

16.

Geusens, Piet, Philip N. Sambrook, & Robert Lindsay. (1998). Osteoporosis in clinical practice : a practical guide for diagnosis and treatment. Springer eBooks. 7 indexed citations

17.

Spector, Timothy D., Richard Keen, Nigel Arden, et al.. (1995). Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ. 310(6991). 1357–1360. 157 indexed citations

18.

Nguyen, Tuan V., Philip N. Sambrook, P J Kelly, et al.. (1993). Prediction of osteoporotic fractures by postural instability and bone density.. BMJ. 307(6912). 1111–1115. 471 indexed citations

19.

Kelly, Paul J., Nicholas Pocock, Philip N. Sambrook, & John A. Eisman. (1990). Dietary calcium, sex hormones, and bone mineral density in men.. BMJ. 300(6736). 1361–1364. 128 indexed citations

20.

Pocock, Nicholas, John A. Eisman, John L. Hopper, et al.. (1987). Genetic determinants of bone mass in adults. A twin study.. Journal of Clinical Investigation. 80(3). 706–710. 1022 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact